A $14.5 Million Exit Completes a Two-Year Retreat

Sponsored:

Monday, August 3, 2026

Healthcare companies are narrowing around what they do best. Rather than carrying unrelated business lines, many are divesting noncore assets and redirecting the capital toward higher margin services, proprietary technology, and the operations where they hold a genuine competitive position.

Shares of Vaso Corporation (OTCQX: VASO) are climbing Monday after the company completed the sale of NetWolves Network Services LLC to COEO Solutions, LLC for $14.5 million in cash. The deal closed July 31 and was structured as a sale of equity, marking the final step in Vaso's exit from information technology.

Vaso operates through two healthcare businesses. VasoHealthcare serves as the professional sales arm for GE HealthCare's diagnostic imaging and ultrasound products, while VasoMedical designs and manufactures proprietary medical devices, including the Biox series, and operates the ARCS cloud-based SaaS platform. Both will continue running as they do today.

NetWolves had operated as Vaso's managed network services and connectivity business, providing network design, redundancy, application device management, real-time monitoring, reporting, and support systems. Its offerings spanned connectivity, security, managed services, cloud, and professional services, along with single-source billing. COEO provides managed network and cloud communications solutions to small and mid-sized multi-location enterprises, placing NetWolves under an owner focused exclusively on that market.

The sale follows a review of Vaso's long-term business strategy. Together with the November 2025 divestiture of VasoHealthcare IT Corp., it completes the company's wind-down of the entire IT segment operating under VasoTechnology, Inc.

"This transaction allows Vaso to focus its resources on the continued development of its healthcare businesses through VasoHealthcare and VasoMedical," said Dr. Jun Ma, President and Chief Executive Officer. "We appreciate the contributions of the NetWolves team and their service to customers over the years."

The purchase price is subject to customary post-closing adjustments tied to net working capital, closing cash, closing indebtedness, unpaid seller expenses, and escrows, as described in the purchase agreement. Additional detail appears in the Form 8-K filed with the Securities and Exchange Commission on July 31. The DAK Group, Ltd. advised Vaso financially, with Barley Snyder LLP serving as legal counsel. Vaso expects to support an orderly transition for NetWolves customers, employees, vendors, and partners.

What remains is a considerably simpler company: sales services for a major imaging partner, a proprietary device line, and a software platform, all pointed at the same end market.

Shares of VASO are up 34.3% to $0.255 in Monday morning trading.

Sponsored: